Rafferty Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $664K | Sell |
|
|||||
|
2025
Q2 | $490K | Sell |
|
|||||
|
2025
Q1 | $524K | Sell |
|
|||||
|
2024
Q4 | $977K | Sell |
|
|||||
|
2024
Q3 | $1.51M | Sell |
|
|||||
|
2024
Q2 | $1.9M | Sell |
|
|||||
|
2024
Q1 | $5.29M | Buy |
|
|||||
|
2023
Q4 | $3.57M | Sell |
|
|||||
|
2023
Q3 | $3.39M | Sell |
|
|||||
|
2023
Q2 | $4.55M | Sell |
|
|||||
|
2023
Q1 | $4.95M | Sell |
|
|||||
|
2022
Q4 | $3.55M | Sell |
|
|||||
|
2022
Q3 | $3.87M | Buy |
|
|||||
|
2022
Q2 | $3.15M | Sell |
|
|||||
|
2022
Q1 | $8.15M | Buy |
|
|||||
|
2021
Q4 | $8.16M | Buy |
|
|||||
|
2021
Q3 | $7.59M | Sell |
|
|||||
|
2021
Q2 | $6.32M | Buy |
|
|||||
|
2021
Q1 | $2.78M | Buy |
|
|||||
|
2020
Q4 | $382K | Sell |
|
|||||
|
2020
Q3 | $2.21M | Buy |
|